Clarivate CLVT Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Academia & Government Group | $1.26B-4.0% | $1.27B-4.6% | $1.3B-2.0% | $1.29B-3.3% | $1.31B-1.1% | |
| Intellectual Property Group | $803.9M+0.1% | $799.4M-1.5% | $802.1M-3.1% | $804.1M-4.3% | $803.2M-6.0% | |
| Life Sciences & Healthcare | $384.8M-7.2% | $389.8M-6.9% | $402.5M-5.6% | $410.8M-5.3% | $414.6M-5.8% | |
| Royalty And Other Product Expense by Business | ||||||
| Academia & Government Group | $205.4M-15.3% | $215.4M-13.3% | $238.1M-1.0% | $233.1M-4.8% | $242.6M-1.7% | |
| Intellectual Property Group | $73.4M+1.9% | $75.5M-0.8% | $75.4M-4.2% | $74.6M-11.7% | $72M-20.5% | |
| Life Sciences & Healthcare | $37.3M+0.3% | $37.3M-0.8% | $37.8M-1.5% | $37.1M-8.3% | $37.2M-11.1% | |
| Other Cost and Expense, Operating by Business | ||||||
| Academia & Government Group | $48.1M+13.4% | $47.3M+7.5% | $40.7M-11.2% | $42.2M-4.0% | $42.4M-5.3% | |
| Intellectual Property Group | $24.1M-4.0% | $23.6M-9.6% | $24.6M-6.8% | $25.4M-2.3% | $25.1M-2.3% | |
| Life Sciences & Healthcare | $10.9M-5.2% | $10.4M-15.4% | $11.3M-15.8% | $11.4M-15.2% | $11.5M-17.1% | |
| Adjusted EBITDA by Business | ||||||
| Academia & Government Group | $550.8M-2.4% | $548M-2.8% | $563.3M+1.0% | $556.8M-0.9% | $564.1M+1.3% | |
| Intellectual Property Group | $340.7M-3.8% | $334.1M-6.8% | $340.5M-8.1% | $349.7M-7.5% | $354.2M-8.9% | |
| Life Sciences & Healthcare | $118.3M-14.9% | $119.7M-13.3% | $128.7M-11.4% | $138M-8.3% | $139M-10.5% | |
| Technology Expenses by Business | ||||||
| Academia & Government Group | $80.2M+0.1% | $78.8M-2.1% | $79M-0.5% | $78.8M-0.4% | $80.1M+4.4% | |
| Intellectual Property Group | $51.4M+8.9% | $50.9M+9.9% | $50.1M+9.5% | $47.8M+4.6% | $47.2M+5.2% | |
| Life Sciences & Healthcare | $28.2M+1.8% | $28.6M+5.5% | $28.8M+10.7% | $27.2M+5.6% | $27.7M+11.8% | |
| Outside Service Expense by Business | ||||||
| Academia & Government Group | $32M-16.9% | $33.8M-15.3% | $35.7M-11.7% | $37.2M-11.6% | $38.5M-9.9% | |
| Intellectual Property Group | $19.4M-11.8% | $20.9M-0.9% | $22M+5.9% | $22.2M+5.0% | $22M+0.8% | |
| Life Sciences & Healthcare | $10M-19.4% | $10.6M-18.5% | $11M-17.9% | $12.3M-8.9% | $12.4M-11.4% | |
| People-Related Expenses by Business | ||||||
| Academia & Government Group | $341.8M-0.6% | $342.7M-2.0% | $339.8M-3.8% | $337.3M-6.1% | $343.7M-3.7% | |
| Intellectual Property Group | $294.9M+4.3% | $294.4M+3.9% | $289.5M+2.3% | $284.4M+0.1% | $282.7M+0.4% | |
| Life Sciences & Healthcare | $180.1M-3.6% | $183.2M-4.0% | $184.9M-3.3% | $184.8M-4.2% | $186.8M-2.6% | |
| Restructuring costs by Business | ||||||
| Academia & Government Group | $13.7M-10.5% | $21.2M+203% | $21.4M+193% | $19.8M+183% | $15.3M+17.7% | |
| Intellectual Property Group | $13.3M+37.1% | $15.7M+171% | $15.3M+159% | $11.1M+79.0% | $9.7M+6.6% | |
| Life Sciences & Healthcare | $11M+13.4% | $13.8M+103% | $14.5M+49.5% | $12.4M+27.8% | $9.7M-21.1% | |
| Revenue by Product | ||||||
| Re-occurring Revenues | $436.9M+0.9% | $434.2M+1.0% | $432.1M-1.1% | $433.5M-0.8% | $433.2M-1.4% | |
| Subscription revenues | $1.61B+0.1% | $1.61B-1.3% | $1.61B-1.5% | $1.61B-0.9% | $1.61B-1.0% | |
| Transactional and other revenues | $395.7M-18.2% | $415.5M-16.9% | $462.4M-9.3% | $454.4M-15.5% | $483.7M-12.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Clarivate break its business down?
- Clarivate (CLVT) reports revenue by business across 3 parts — Academia & Government Group, Intellectual Property Group and Life Sciences & Healthcare. Each is extracted from the segment footnotes and tracked over time.
- Where does Clarivate's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Clarivate's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
